Ruxolitinib in adult dermatomyositis with anti-TIF1γ antibody: a case report and literature review
Ruxolitinib is a selective JAK1/2 inhibitor, and its application in treating adult-onset dermatomyositis(DM) has rarely been described. Here, we report a case of an adult-onset DM patient with anti-TIF1γ antibody, who also suffered from essential throm…